TipRanks
Immunocore Holdings (IMCR)
NASDAQ:IMCR
US Market
IMCR
Immunocore Holdings
RESEARCH TOOLSreports
Want to see IMCR full AI Analyst Report?

Immunocore Holdings (IMCR) Income Statement

257 Followers

Immunocore Holdings Income Statement

Last quarter (Q2 2026), Immunocore Holdings's total revenue was £115.93M, an increase of 18.34% from the same quarter last year. In Q2, Immunocore Holdings's net income was £-808.00K. See Immunocore Holdings’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 297.57M$ 247.98M£ 197.39M£ 144.23M£ 27.04M
Gross Profit
$ 291.36M$ 242.44M£ 196.57M£ 138.94M£ 27.04M
Operating Expenses
$ 325.09M$ 298.77M£ 243.77M£ 181.71M£ 156.46M
Depreciation and Amortization
$ 2.43M$ 4.20M£ 3.24M--
EBITDA
$ 387.18K$ -37.66M£ -40.87M--
Operating Income
$ -33.74M$ -56.28M£ -47.20M£ -42.77M£ -129.42M
Other Income/Expenses
$ 19.53M$ 14.01M£ -982.07K£ 8.95M£ -3.92M
Pretax Income
$ -14.21M$ -42.32M£ -48.19M£ -33.82M£ -133.34M
Net Income
$ -26.42M$ -40.81M£ -43.75M£ -43.46M£ -133.45M
Per Share Metrics
Basic EPS
$ -0.53$ -1.02£ -0.89£ -0.95£ -3.13
Diluted EPS
$ -0.53$ -1.02£ -0.89£ -0.95£ -3.00
Weighted Average Shares Outstanding
 50.35M 49.99M 48.89M 45.71M 42.49M
Weighted Average Shares Outstanding (Diluted)
 50.35M 49.99M 48.89M 45.71M 43.86M

Immunocore Holdings Earnings and Revenue History